awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q36610517-46FC9E8D-7C95-469B-83D8-D170241AE5D7
Q36610517-46FC9E8D-7C95-469B-83D8-D170241AE5D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36610517-46FC9E8D-7C95-469B-83D8-D170241AE5D7
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
P932
Q36610517-46FC9E8D-7C95-469B-83D8-D170241AE5D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36610517-46FC9E8D-7C95-469B-83D8-D170241AE5D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b7345ffb9ad67a378d707dcf075e9db278137206
P932
2360206
http://www.w3.org/2001/XMLSchema#string